Reports

Global BCG Vaccine Market Data Survey Report 2015-2025

Summary BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme. Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive. The global BCG Vaccine market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major End-Use Global market size by Major Type Key manufacturers are included based on company profile, sales data and product specifications etc.: Merck Sanofi Pasteur Japan BCG Lab China National Biotec Serum Institute of India Intervax GSBPL Major applications as follows: Hospitals Clinics Others Major Type as follows: Immune BCG Therapy BCG Regional market size, production data and export & import: Asia-Pacific North America Europe South America Middle East & Africa

Last updated 01-02-2020 Read More